2,435 results on '"MS"'
Search Results
2. Revenues, costs, and contribution margins of major inpatient cardiovascular procedures within the Medicare population
3. Health status outcomes after acute myocardial infarction in patients without standard modifiable risk factors
4. Real-world exploration of LDL-cholesterol management in patients with atherosclerotic cardiovascular disease
5. Design and rationale of a pragmatic randomized clinical trial of early dronedarone versus usual care to change and improve outcomes in persons with first-detected atrial fibrillation – the CHANGE AFIB study
6. Rationale and design of the women's ischemia syndrome evaluation mechanisms of coronary microvascular dysfunction leading to preheart failure with preserved ejection fraction (WISE Pre-HFPEF)
7. Design, rationale, and characterization of the mobile health based occupational cardiovascular risk intervention study (mHealth-OPEN study)
8. Design and rationale of penn medicine healthy heart, a randomized trial of effectiveness of a centrally organized approach to blood pressure and cholesterol improvement among patients at elevated risk of atherosclerotic cardiovascular disease
9. Contributors to high left ventricular ejection fraction in women with ischemia and no obstructive coronary artery disease: Results from the Women's Ischemia Syndrome Evaluation—Coronary Vascular Dysfunction (WISE-CVD) Study
10. Variations in antihypertensive medication treatment and blood pressure control among Veterans with HIV and existing hypertension
11. Milvexian vs apixaban for stroke prevention in atrial fibrillation: The LIBREXIA atrial fibrillation trial rationale and design
12. RAndomized Cluster Evaluation of Cardiac ARrest Systems (RACE-CARS) trial: Study rationale and design
13. Rationale and design of INFINITY-SWEDEHEART: A registry-based randomized clinical trial comparing clinical outcomes of the sirolimus-eluting DynamX bioadaptor to the zotarolimus-eluting Resolute Onyx stent
14. Malignant left ventricular hypertrophy and risk of cognitive impairment in SPRINT MIND trial
15. Design and rationale of the social determinants of the risk of hypertension in women of reproductive age (SAFE HEART) study: An American Heart Association research goes red initiative
16. Examining lack of referrals to heart valve specialists as mechanisms of potential underutilization of aortic valve replacement
17. Baseline characteristics including blood and urine metal levels in the Trial to Assess Chelation Therapy 2 (TACT2)
18. Comparing the outcomes of rheumatic heart disease in pregnancy complicated with and without atrial fibrillation: A propensity score matched analysis
19. Design and rationale of the Comprehensive intelligent Hypertension managEment SyStem (CHESS) evaluation study: A cluster randomized controlled trial for hypertension management in primary care
20. Rationale and design of the DEFIANCE study: A randomized controlled trial of mechanical thrombectomy versus anticoagulation alone for iliofemoral deep vein thrombosis
21. Design and rationale of the COVID vaccine-associated myocarditis/pericarditis (CAMP) study
22. Primary medication adherence in Medicare beneficiaries prescribed sacubitril-valsartan or renin-angiotensin system blockers for heart failure with reduced ejection fraction
23. Effect of apixaban versus vitamin K antagonist and aspirin versus placebo on days alive and out of hospital: An analysis from AUGUSTUS
24. Use of e-cigarettes, traditional combustible cigarettes, and high sensitivity C-reactive protein: The Cross Cohort Collaboration
25. Pregnancy care experiences for adults with congenital heart disease in the United States
26. Brief report: U.S. trends in use of colchicine by cardiologists and other specialties, 2018 to 2024
27. Effects of fortified eggs and time-restricted eating on cardiometabolic health: The prosperity trial
28. Assessment of the CLOT (children's likelihood of thrombosis) real-time risk prediction model of hospital-associated venous thromboembolism in children with congenital heart disease
29. Angiographic characteristics of patients with STEMI and COVID-19: Insights from NACMI registry
30. Prognostic implications of volume status assessed by blood volume analysis in ambulatory heart failure
31. Characterizing advanced heart failure risk and hemodynamic phenotypes using interpretable machine learning
32. Gamification-augmented home-based exercise for peripheral artery disease: Rationale and design of the GAMEPAD Study
33. Radial artery vs right internal mammary artery as a second conduit during coronary artery bypass grafting
34. Reminders embedded in PCI reports to optimize discharge diabetes mellitus care (REMIND-DM): Rationale, design, and baseline characteristics
35. Occult cancer in patients with unprovoked venous thromboembolism: Rationale, design, and methods of the VaLRIETEs study and the SOME-RIETE trial
36. The left atrial appendage exclusion for prophylactic stroke reduction (LEAAPS) trial: Rationale and design
37. Rationale and design of the prevail global trial program evaluating the prevail drug-coated balloon in patients with in-stent restenosis and de novo small vessel disease
38. Type 2 diabetes disease and management patterns across a large, diverse healthcare system: Issues and opportunities for guideline-directed therapies
39. Hospital-level variation in cardiac rehabilitation metrics
40. Discontinuation of SGLT-2i and GLP-1RA among persons with Type 2 diabetes and atherosclerotic cardiovascular disease treated in US cardiology clinics
41. Patterns of diuretic titration during inpatient management of acute decompensated heart failure
42. Influence of left ventricular ejection fraction in patients undergoing contemporary pLVAD-supported high-risk PCI
43. Study of heart function in PRE-Eclampsia during and after PreGnancy (SHePREG): The pilot cohort
44. Unfavorable social determinants of health and mortality risk by cardiovascular disease status: Findings from a National Study of United States Adults
45. Trends in cancer and heart failure related mortality in adult US population: A CDC WONDER database analysis from 1999 to 2020
46. Rationale and design of CHD PULSE: Congenital Heart Disease Project to Understand Lifelong Survivor Experience
47. Rule-based natural language processing to examine variation in worsening heart failure hospitalizations by age, sex, race and ethnicity, and left ventricular ejection fraction
48. Assessing methods to ascertain persistence and adherence of oral anticoagulants in patients with atrial fibrillation
49. Enrollment strategies in the era of digital revolution: Experience from a remote health management program
50. Antihypertensive medication prescription dispensation among pregnant women in the United States: A cohort study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.